Osaic Holdings
PTGX icon

Osaic Holdings’s Protagonist Therapeutics PTGX Stock Holding History

Osaic Holdings’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
1,776
+579
+48% +$60.5K ﹤0.01% 4363
2026
Q1 		$126K Sell
1,197
-3,004
-72% -$266K ﹤0.01% 4508
2025
Q4 		$367K Buy
4,201
+2,810
+202% +$230K ﹤0.01% 3618
2025
Q3 		$91K Buy
1,391
+206
+17% +$11.7K ﹤0.01% 4865
2025
Q2 		$65.5K Buy
1,185
+525
+80% +$25.2K ﹤0.01% 4845
2025
Q1 		$31.9K Buy
660
+68
+11% +$2.85K ﹤0.01% 5030
2024
Q4 		$22.9K Buy
592
+414
+233% +$18K ﹤0.01% 5256
2024
Q3 		$8.01K Sell
178
-292
-62% -$11.8K ﹤0.01% 5952
2024
Q2 		$16.3K Sell
470
-2,081
-82% -$60.9K ﹤0.01% 5481
2024
Q1 		$73.8K Buy
2,551
+2,270
+808% +$61.8K ﹤0.01% 4466
2023
Q4 		$6.43K Sell
281
-31
-10% -$542 ﹤0.01% 6052
2023
Q3 		$5.2K Buy
+312
New +$6.05K ﹤0.01% 6256
2022
Q2 		– Sell
-57
Closed -$1K – 7537
2022
Q1 		$1K Hold
57
– – ﹤0.01% 7099
2021
Q4 		$2K Hold
57
– – ﹤0.01% 7043
2021
Q3 		$1K Sell
57
-173
-75% -$7.38K ﹤0.01% 7060
2021
Q2 		$11K Buy
230
+37
+19% +$1.22K ﹤0.01% 6011
2021
Q1 		$5K Sell
193
-966
-83% -$24.4K ﹤0.01% 6170
2020
Q4 		$24K Buy
1,159
+616
+113% +$13.3K ﹤0.01% 5050
2020
Q3 		$11K Sell
543
-9,540
-95% -$179K ﹤0.01% 5226
2020
Q2 		$178K Buy
10,083
+10,000
+12,048% +$125K ﹤0.01% 3236
2020
Q1 		$1K Buy
+83
New +$622 ﹤0.01% 5896

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Osaic Holdings's PTGX Position: Q2 2026 in Review

Osaic Holdings increased its Protagonist Therapeutics (PTGX) stake by 48% in Q2 2026, buying an estimated $60.5K and bringing the position to 1,776 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #4363.

Osaic Holdings first reported a position in PTGX in Q1 2020 and has held it in 21 quarters since. The position peaked at $367K in Q4 2025. 343 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Osaic Holdings held 1,776 shares of Protagonist Therapeutics worth $218K as of Q2 2026.
  • Osaic Holdings bought 579 Protagonist Therapeutics shares in Q2 2026, an estimated $60.5K.
  • Protagonist Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4363 holding.
  • Osaic Holdings first reported a position in Protagonist Therapeutics in Q1 2020 and has held it in 21 quarters since.
  • Osaic Holdings's Protagonist Therapeutics position peaked at $367K in Q4 2025.
  • 343 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.